Suppr超能文献

脉-动脉体外膜肺氧合的最佳血压是多少?平均动脉压对生存率的影响。

What Is the Optimal Blood Pressure on Veno-Arterial Extracorporeal Membrane Oxygenation? Impact of Mean Arterial Pressure on Survival.

机构信息

From the Division of Cardiothoracic Surgery, Department of Surgery, Thomas Jefferson University, Philadelphia, Pennsylvania.

出版信息

ASAIO J. 2019 May/Jun;65(4):336-341. doi: 10.1097/MAT.0000000000000824.

Abstract

Blood pressure management is crucial for patients on veno-arterial extracorporeal membrane oxygenation (VA ECMO). Lower pressure can lead to end-organ malperfusion, whereas higher pressure may compete with ECMO flow and cardiac output. The impact of mean arterial pressure (MAP) on outcomes of patients on VA ECMO was evaluated. Patients who were supported on VA ECMO from September 2010 to March 2016 were retrospectively analyzed for average MAP throughout their course on ECMO, excluding the first and last day. Survival and complications observed during ECMO were investigated by classifying patients into groups based on their average MAP. A total of 116 patients were identified. Average MAP was significantly higher in patients who survived to discharge (82 ± 5.6 vs. 78 ± 5.5 mm Hg, p = 0.0003). There was a positive association between MAP and survival. Survival was best with MAP higher than 90 mm Hg (71%) and worst with MAP less than 70 mm Hg, where no patient survived. MAP was an independent predictor of survival to discharge by multivariate analysis (odds ratio 1.17, p = 0.013). Vasopressors were used more frequently in patients with lower pressure (coefficient -3.14, p = 0.005) without affecting survival (odds ratio 0.95, p = 0.95). Although the MAP did not affect the probability of strokes or bleeding complications, patients with a higher MAP had a lower incidence of kidney injury (p = 0.007). In conclusion, survival of patients on VA ECMO was significantly greater with a higher MAP, without being affected by prolonged vasopressor use.

摘要

血管内动静脉体外膜肺氧合(VA ECMO)患者的血压管理至关重要。较低的血压会导致终末器官灌注不良,而较高的血压可能会与 ECMO 流量和心输出量竞争。评估平均动脉压(MAP)对 VA ECMO 患者结局的影响。对 2010 年 9 月至 2016 年 3 月接受 VA ECMO 支持的患者进行回顾性分析,排除 ECMO 治疗的第一天和最后一天,分析其整个 ECMO 治疗过程中的平均 MAP。根据平均 MAP 将患者分为不同组,研究 ECMO 期间观察到的生存率和并发症。共确定 116 例患者。存活至出院的患者平均 MAP 明显较高(82 ± 5.6 与 78 ± 5.5 mmHg,p = 0.0003)。MAP 与生存率呈正相关。MAP 高于 90 mmHg 时生存率最佳(71%),MAP 低于 70 mmHg 时最差(无患者存活)。多因素分析显示 MAP 是出院生存率的独立预测因素(优势比 1.17,p = 0.013)。MAP 较低的患者更频繁地使用血管加压药(系数-3.14,p = 0.005),但不影响生存率(优势比 0.95,p = 0.95)。尽管 MAP 并未影响中风或出血并发症的概率,但 MAP 较高的患者发生肾脏损伤的概率较低(p = 0.007)。总之,VA ECMO 患者的生存率随着 MAP 的升高而显著提高,且不会因长时间使用血管加压药而受到影响。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验